✦ LIBER ✦

The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients

✍ Scribed by J. Eileen Hay; Albert J. Czaja; Jorge Rakela; Jurgen Ludwig

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 678 KB
Volume: 9
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840090205

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multinational, randomised, 12-week stu

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease

✍ Roy W. Jones; Hilkka Soininen; Klaus Hager; Dag Aarsland; Peter Passmore; Anita 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

## Abstract ## Objectives To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). ## Methods Pati

A randomised, double-blind comparison of

A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia

✍ Ingvar Karlsson; Jan Godderis; Carlos Augusto De Mendonça Lima; Harald Nygaard; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 3 views

Depression is the most common psychiatric disorder among the elderly and in old age may interact with emotional and cognitive functioning. Depression in old age has been shown to be associated with degenerative changes in the brain. It is, therefore, important that in this patient population antidep

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

Sequential therapy with recombinant inte

Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: Clinical responsiveness to recombinant ifn-α correlates with the degree of receptor down-regulation

✍ H. H. Bartsch; K. Pfizenmaier; A. Hanusch; P. Scheurich; U. Ücer; G. A. Nagel 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 710 KB

Natural and recombinant interferons (IFNs) have already demonstrated therapeutic efficacy, including cytogenetic re- missions, in patients with chronic myelocytic leukemia (CML). We investigated at the level of ligand-receptor interaction the question whether heterogeneity of receptor number or affi